Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,854
datasets available to search
ShareScore release 0.8.0
Dataset results
2,854 results for “Hepatocellular carcinoma”
Mts105 for Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06689540. IPD Sharing: NO. Countries: 1. Publications: 0.
SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07274774. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
ClinicalTrials.gov study NCT06041490. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05304481. IPD Sharing: NO. Countries: 1. Publications: 0.
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT06852820. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
ClinicalTrials.gov study NCT06096779. IPD Sharing: YES. Countries: 2. Publications: 0.
Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01570166. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT01392131. IPD Sharing: Not stated. Countries: 1. Publications: 0.
"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04317248. IPD Sharing: NO. Countries: 1. Publications: 0.
SBRT + TACE for Primary Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00746655. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05349331. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Proteomic Analysis of Human Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01177631. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery
ClinicalTrials.gov study NCT01690715. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HAIC Combined with Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)
ClinicalTrials.gov study NCT06860490. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04797884. IPD Sharing: YES. Countries: 1. Publications: 0.
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
ClinicalTrials.gov study NCT00561522. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02061956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00384800. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study
ClinicalTrials.gov study NCT05602974. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
ClinicalTrials.gov study NCT04053972. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.